AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
TP53 polymorphism, HPV infection, and risk of cervical cancer
Authors: Klug, SJ Wilmotte, R Santos, C Almonte, M Herrero, R Guerrero, I Caceres, E Peixoto-Guimaraes, D Lenoir, G Hainaut, P Walboomers, JMM Munoz, N
Citation: Sj. Klug et al., TP53 polymorphism, HPV infection, and risk of cervical cancer, CANC EPID B, 10(9), 2001, pp. 1009-1012
Dermoid cysts revealed by meningitis with medullary compression.
Authors: Raqbi, F Zerah, M Bodemer, C Lenoir, G
Citation: F. Raqbi et al., Dermoid cysts revealed by meningitis with medullary compression., ARCH PED, 8(5), 2001, pp. 499-503
Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China
Authors: Guimaraes, DP Lu, SH Snijders, P Wilmotte, R Herrero, R Lenoir, G Montesano, R Meijer, CJLM Walboomers, J Hainaut, P
Citation: Dp. Guimaraes et al., Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China, CANCER LETT, 162(2), 2001, pp. 231-235
Sputum itraconazole concentrations in cystic fibrosis patients
Authors: Sermet-Gaudelus, I Lesne-Hulin, A Lenoir, G Singlas, E Berche, P Hennequin, C
Citation: I. Sermet-gaudelus et al., Sputum itraconazole concentrations in cystic fibrosis patients, ANTIM AG CH, 45(6), 2001, pp. 1937-1938
Hereditary hypophosphatemic rickets with hypercalciuria: Report of a new kindred
Authors: Sermet-Gaudelus, I Garabedian, M Dechaux, M Lenoir, G Rey, J Tieder, M
Citation: I. Sermet-gaudelus et al., Hereditary hypophosphatemic rickets with hypercalciuria: Report of a new kindred, NEPHRON, 88(1), 2001, pp. 83-86
French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients
Authors: Pons, G Marchand, MC d'Athis, P Sauvage, E Foucard, C Chaumet-Riffaud, P Sautegeau, A Navarro, J Lenoir, G
Citation: G. Pons et al., French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients, PEDIAT PULM, 30(1), 2000, pp. 25-31
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22
Authors: Lucotte, G Bathelier, C Mercier, G Gerard, N Lenoir, G Semonin, O Fontaine, K
Citation: G. Lucotte et al., Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22, GEN COUNSEL, 11(4), 2000, pp. 329-334
Normal sweat test does not exclude the diagnosis of cystic fibrosis
Authors: Sermet-Gaudelus, I Bonnefont, JP Khoa, ATN Lenoir, G
Citation: I. Sermet-gaudelus et al., Normal sweat test does not exclude the diagnosis of cystic fibrosis, ARCH PED, 7(6), 2000, pp. 594-596
Antibiotic therapy in cystic fibrosis
Authors: Sermet-Gaudelus, I Ferroni, A Gaillard, JL Silly, C Chretiennot, C Lenoir, G Berche, P
Citation: I. Sermet-gaudelus et al., Antibiotic therapy in cystic fibrosis, ARCH PED, 7(6), 2000, pp. 645-656
Pharmacologic particularities of antibiotics in cystic fibrosis
Authors: Sermet-Gaudelus, I Hulin, A Ferroni, A Silly, C Gaillard, JL Berche, P Lenoir, G
Citation: I. Sermet-gaudelus et al., Pharmacologic particularities of antibiotics in cystic fibrosis, ARCH PED, 7(5), 2000, pp. 519-528
Molecular characterization of germline NF2 gene rearrangements
Authors: Legoix, P Sarkissian, HD Cazes, L Giraud, S Sor, F Rouleau, GA Lenoir, G Thomas, G Zucman-Rossi, J
Citation: P. Legoix et al., Molecular characterization of germline NF2 gene rearrangements, GENOMICS, 65(1), 2000, pp. 62-66
Haemophagocytic syndrome in Plasmodium falciparum malaria
Authors: Sermet-Gaudelus, I Abadie, V Stambouli, F Hennequin, C Lenoir, G Gendrel, D
Citation: I. Sermet-gaudelus et al., Haemophagocytic syndrome in Plasmodium falciparum malaria, ACT PAEDIAT, 89(3), 2000, pp. 368-369
Characterization of inflammatory reaction in upper airways of cystic fibrosis patients
Authors: Lesprit, E Escudier, E Roger, G Pruliere, V Lenoir, G Reinert, P Coste, A
Citation: E. Lesprit et al., Characterization of inflammatory reaction in upper airways of cystic fibrosis patients, HIST HISTOP, 15(2), 2000, pp. 395-402
Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma
Authors: Gutierrez, MI Hamdy, N Bhatia, K Bornkamm, G Lenoir, G Epelman, S Magrath, I
Citation: Mi. Gutierrez et al., Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma, INT J PED H, 6(3), 1999, pp. 161-168
Characterisation of 16 polymorphic markers in the NF2 gene: Application tohemizygosity detection
Authors: Legoix, P Legrand, MF Ollagnon, E Lenoir, G Thomas, G Zucman-Rossi, J
Citation: P. Legoix et al., Characterisation of 16 polymorphic markers in the NF2 gene: Application tohemizygosity detection, HUM MUTAT, 13(4), 1999, pp. 290-293
Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum
Authors: Witko-Sarsat, V Halbwachs-Mecarelli, L Schuster, A Nusbaum, P Ueki, I Canteloup, S Lenoir, G Descamps-Latscha, B Nadel, JA
Citation: V. Witko-sarsat et al., Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum, AM J RESP C, 20(4), 1999, pp. 729-736
Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
Authors: Witko-Sarsat, V Sermet-Gaudelus, I Lenoir, G Descamps-Latscha, B
Citation: V. Witko-sarsat et al., Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?, MEDIAT INFL, 8(1), 1999, pp. 7-11
Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report
Authors: Sermet-Gaudelus, I Stoven, V Annereau, JP Witko-Sarsat, V Reinert, P Guyot, M Descamps-Latscha, B Lallemand, JY Lenoir, G
Citation: I. Sermet-gaudelus et al., Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report, MEDIAT INFL, 8(1), 1999, pp. 13-15
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2
Authors: Foray, N Randrianarison, V Marot, D Perricaudet, M Lenoir, G Feunteun, J
Citation: N. Foray et al., Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2, ONCOGENE, 18(51), 1999, pp. 7334-7342
Rapid improvement of intracranial tuberculomas after addition of ofloxacinto first-line antituberculosis treatment
Authors: Sermet-Gaudelus, I Stambouli, F Abadie, V Goutieres, F Lenoir, G Gendrel, D Gaillard, JL
Citation: I. Sermet-gaudelus et al., Rapid improvement of intracranial tuberculomas after addition of ofloxacinto first-line antituberculosis treatment, EUR J CL M, 18(10), 1999, pp. 726-728
Cryptic exons as a source of increased diversity of Ewing tumor-associatedEWS-FLI1 chimeric products
Authors: Kovar, H Jugovic, D Melot, T Zoubek, A Lenoir, G Fink, FM Philip, I Turc-Carel, C Thomas, G Zucman-Rossi, J
Citation: H. Kovar et al., Cryptic exons as a source of increased diversity of Ewing tumor-associatedEWS-FLI1 chimeric products, GENOMICS, 60(3), 1999, pp. 371-374
Cystic fibrosis: home antibiotic therapy
Authors: Lenoir, G Monnier, A Marais, P
Citation: G. Lenoir et al., Cystic fibrosis: home antibiotic therapy, REV FR ALLE, 39(6), 1999, pp. 520-522
An update on DNA-Based BRCA1/BRCA2 genetic counseling in hereditary breastcancer
Authors: Lynch, HT Watson, P Tinley, S Snyder, C Durham, C Lynch, J Kirnarsky, Y Serova, O Lenoir, G Lerman, C Narod, SA
Citation: Ht. Lynch et al., An update on DNA-Based BRCA1/BRCA2 genetic counseling in hereditary breastcancer, CANC GENET, 109(2), 1999, pp. 91-98
Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer
Authors: Shugart, YY Cour, C Renard, H Lenoir, G Goldgar, D Teare, D Easton, D Rahman, N Gusterton, R Seal, S Barfoot, R Stratton, M Mangion, J Peelen, T van den Ouweland, A Meijers, H Devilee, P Eccles, D Lynch, H Weber, B Stoppa-Lyonnet, D Bignon, YJ
Citation: Yy. Shugart et al., Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer, J MED GENET, 36(9), 1999, pp. 720-721
Risultati: 1-25 | 26-28